Skip to Content

1,182 Results Found

  • Review
  • Open Access
536 Views
36 Pages

Principles, Optimization, Applications, and Future Prospects of mRNA Vaccine Technology

  • Lang Qin,
  • Jinming Yang,
  • Yu Hu,
  • Qiong Li and ,
  • Tongna Guo,
  • Jia Tang and
  • Wenxue Zhao
  • + 2 authors+ 0 author

17 October 2026

mRNA vaccines have emerged as a promising platform in vaccinology, enabling rapid and flexible antigen design. By delivering mRNA encoding target antigens, they allow in situ protein expression and induction of adaptive immune responses. Advances in...

(This article belongs to the Special Issue Next-Generation Synthetic Microbiomics: From AI-Driven Design to Clinical Application)
  • Article
  • Open Access
27 Citations
8,625 Views
16 Pages

Background: Lipid nanoparticles (LNPs) represent one of the most effective non-viral vectors for nucleic acid delivery and have demonstrated clinical success in siRNA therapies and mRNA vaccines. While considerable research has focused on optimizing...

(This article belongs to the Special Issue Impact of Lipid Nanoparticle Physicochemical Properties on mRNA Vaccine)
  • Article
  • Open Access
1,063 Views
18 Pages

Algorithm-Optimized H5 Influenza mRNA Vaccine Induces Broad Immune Responses

  • Liangliang Wang,
  • Zhengda Peng,
  • Chenchen He,
  • Jie Zhang and ,
  • Pengju Yu,
  • Weijin Huang,
  • Youchun Wang and
  • Chenyan Zhao
  • + 3 authors+ 0 author

The high case fatality rate, cross-species transmission, and ongoing evolution of H5 avian influenza viruses pose an imminent threat of an influenza pandemic, particularly with the currently predominant clade 2.3.4.4b lineage. Existing seasonal influ...

(This article belongs to the Section Molecular Microbiology)
  • Article
  • Open Access
11 Citations
8,176 Views
16 Pages

ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model

  • Owen Daly,
  • Azita Josefine Mahiny,
  • Sara Majeski,
  • Kevin McClintock and ,
  • Julia Reichert,
  • Gábor Boros,
  • Gábor Tamás Szabó,
  • Jonas Reinholz,
  • Petra Schreiner and
  • Irena Vlatkovic
  • + 13 authors+ 8 authors

Argininosuccinic aciduria (ASA) is a metabolic disorder caused by a deficiency in argininosuccinate lyase (ASL), which cleaves argininosuccinic acid to arginine and fumarate in the urea cycle. ASL deficiency (ASLD) leads to hepatocyte dysfunction, hy...

(This article belongs to the Section Biomedical Engineering and Materials)
  • Article
  • Open Access
178 Citations
37,607 Views
19 Pages

The design of Pfizer/BioNTech and Moderna mRNA vaccines involves many different types of optimizations. Proper optimization of vaccine mRNA can reduce dosage required for each injection leading to more efficient immunization programs. The mRNA compon...

(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19: Version II)
  • Brief Report
  • Open Access
9 Citations
3,368 Views
12 Pages

13 January 2025

Background/Objectives: Approved mRNA vaccines commonly use sequences modified with pseudouridine to enhance translation efficiency and mRNA stability. However, this modification can result in ribosomal frameshifts, reduced immunogenicity, and higher...

(This article belongs to the Special Issue Evaluating the Immune Response to RNA Vaccine)
  • Article
  • Open Access
2 Citations
1,721 Views
16 Pages

Codon Composition in Human Oocytes Reveals Age-Associated Defects in mRNA Decay

  • Pavla Brachova,
  • Lane K. Christenson and
  • Nehemiah S. Alvarez

26 September 2025

Oocytes from women of advanced reproductive age exhibit diminished developmental potential, but the underlying mechanisms remain incompletely defined. Oocyte maturation depends on translational control of maternal mRNA synthesized during growth. We p...

(This article belongs to the Special Issue Aging: From Molecular Mechanisms and Pathophysiology to Novel Therapeutic Approaches (3rd Edition))
  • Article
  • Open Access
15 Citations
6,214 Views
26 Pages

Decoding Codon Bias: The Role of tRNA Modifications in Tissue-Specific Translation

  • Daisuke Ando,
  • Sherif Rashad,
  • Thomas J. Begley,
  • Hidenori Endo and ,
  • Masashi Aoki,
  • Peter C. Dedon and
  • Kuniyasu Niizuma
  • + 2 authors+ 0 author

The tRNA epitranscriptome has been recognized as an important player in mRNA translation regulation. Our knowledge of the role of the tRNA epitranscriptome in fine-tuning translation via codon decoding at tissue or cell levels remains incomplete. We...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
2 Citations
4,688 Views
17 Pages

Optimization of RNA In Situ Hybridization for mRNA Localization Detection in Mature Tissue of Cucumber Seedlings

  • Zixi Liu,
  • Xi Hu,
  • Jing Nie,
  • Xiaojun Li and ,
  • Qing Wang,
  • Wenqian Liu,
  • Tao Wang,
  • Xiaohong Lu,
  • Shunli Gao and
  • Wenna Zhang
  • + 6 authors+ 1 author

29 October 2020

Cucumber (Cucumis sativus L.) is one of the main vegetable crops in China. The physiological cultivation mechanism and gene function characteristics of cucumber are of great significance to the construction of modern agriculture. Due to the low genet...

  • Review
  • Open Access
26 Citations
14,105 Views
15 Pages

31 March 2025

Personalized cancer vaccines are a promising immunotherapy targeting patient-specific tumor neoantigens, yet their design and efficacy remain challenging. Recent advances in artificial intelligence (AI) provide powerful tools to enhance multiple stag...

(This article belongs to the Special Issue Feature Papers in BioChem, 2nd Edition)
  • Article
  • Open Access
17 Citations
5,687 Views
13 Pages

Hydrophobic Optimization of Functional Poly(TPAE-co-suberoyl chloride) for Extrahepatic mRNA Delivery following Intravenous Administration

  • Xueliang Yu,
  • Shuai Liu,
  • Qiang Cheng,
  • Sang M. Lee and ,
  • Tuo Wei,
  • Di Zhang,
  • Lukas Farbiak,
  • Lindsay T. Johnson,
  • Xu Wang and
  • Daniel John Siegwart
  • + 5 authors+ 0 author

Messenger RNA (mRNA) has generated great attention due to its broad potential therapeutic applications, including vaccines, protein replacement therapy, and immunotherapy. Compared to other nucleic acids (e.g., siRNA and pDNA), there are more opportu...

(This article belongs to the Special Issue mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó)
  • Article
  • Open Access
8 Citations
3,882 Views
20 Pages

Investigation on a Freeze-Drying Process for Long-Term Stability of mRNA-LNPs

  • MD Faizul Hussain Khan,
  • Ayyappasamy Sudalaiyadum Perumal and
  • Amine A. Kamen

6 March 2026

Background: Thermostability remains a key bottleneck for equitable access to mRNA-LNPs vaccines, mainly due to cold-chain requirements. Objectives and methods: Here, we optimized freeze-drying formulations by screening excipients (sugars, sugar alcoh...

  • Article
  • Open Access
357 Views
14 Pages

20 September 2026

The efficient expression of recombinant proteins in aquaculture fish poses a significant challenge, partly due to the lack of dedicated bioinformatics tools for species-specific codon usage analysis and optimization. RiboScan (v1.0.0), a portable, si...

(This article belongs to the Section Genetics and Biotechnology)
  • Article
  • Open Access
64 Citations
12,250 Views
16 Pages

Comprehensive Optimization of a Freeze-Drying Process Achieving Enhanced Long-Term Stability and In Vivo Performance of Lyophilized mRNA-LNPs

  • Teresa Alejo,
  • Alfonso Toro-Córdova,
  • Laura Fernández,
  • Andrea Rivero and ,
  • Andrei Mihai Stoian,
  • Luna Pérez,
  • Victor Navarro,
  • Juan Martínez-Oliván and
  • Diego de Miguel
  • + 4 authors+ 0 author

1 October 2024

The success of mRNA vaccines against SARS-CoV-2 has prompted interest in mRNA-based pharmaceuticals due to their rapid production, adaptability, and safety. Despite these advantages, the inherent instability of mRNA and its rapid degradation in vivo...

(This article belongs to the Section Molecular Nanoscience)
  • Article
  • Open Access
1,637 Views
17 Pages

An Optimized RT-qPCR Protocol for Comprehensive Analysis of microRNAs and mRNAs in Mus musculus Brain Tissues

  • Maria V. Lukashevich,
  • Margarita M. Rudenok,
  • Suzanna A. Partevian,
  • Maria I. Shadrina and ,
  • Petr A. Slominsky and
  • Anelya Kh. Alieva
  • + 1 author+ 0 author

Background/Objectives: MicroRNAs are key post-transcriptional regulators involved in various diseases. Despite its status as the gold standard, real-time RT-PCR faces challenges arising from high sequence homology among closely related microRNAs and...

  • Article
  • Open Access
1 Citations
2,605 Views
15 Pages

Increasing Transfection of Human Monocyte-Derived Dendritic Cells by Optimizing Lipid Nanoparticle Ionizable Lipid and mRNA Uridine Modification

  • Izabella Lambart,
  • Daniel Flender,
  • Dana Liu,
  • Jenny Hong Hoang and ,
  • Max Hesse,
  • Diana Campillo-Davo,
  • Eva Lion,
  • Jonas Van Audenaerde,
  • Stefan Schiller and
  • Hannah Zaryouh
  • + 9 authors+ 4 authors

Background/Objectives: Lipid nanoparticles (LNPs) are a prominent example of delivery systems that are used to prevent the degradation of messenger ribonucleic acid (mRNA) and facilitate cell uptake. Improving LNP transfection efficiency requires car...

(This article belongs to the Special Issue Development of Nucleic Acid Delivery System)
  • Article
  • Open Access
1 Citations
4,633 Views
26 Pages

Boosting LNP Performance: Higher Concentrations of Lipid Mixtures Improve In Vivo Gene Expression and Storage Stability

  • Blerina Shkodra,
  • Ashish Muglikar,
  • Janani Thangapandian,
  • Matthias Schumacher and ,
  • Burcu Binici and
  • Yvonne Perrie
  • + 1 author+ 0 author

Background: An efficient formulation of lipid nanoparticles (LNPs) is often considered crucial in the successful development of nucleic acid therapeutics. This study explores the impact of varying the lipid and payload concentrations as starting mate...

(This article belongs to the Section Nanomedicine and Nanotechnology)
  • Article
  • Open Access
35 Citations
8,395 Views
25 Pages

The Optimization and Biological Significance of a 29-Host-Immune-mRNA Panel for the Diagnosis of Acute Infections and Sepsis

  • Yudong D. He,
  • Eric M. Wohlford,
  • Florian Uhle,
  • Ljubomir Buturovic and ,
  • Oliver Liesenfeld and
  • Timothy E. Sweeney
  • + 1 author+ 0 author

28 July 2021

In response to the unmet need for timely accurate diagnosis and prognosis of acute infections and sepsis, host-immune-response-based tests are being developed to help clinicians make more informed decisions including prescribing antimicrobials, order...

(This article belongs to the Special Issue Precision Medicine for Immunology and Immunogenetics)
  • Article
  • Open Access
1,187 Views
25 Pages

Optimized Epitope-Flanking Sequences Enhance Antigen Presentation and T-Cell Responses Following mRNA Vaccination

  • Marie-Pierre Hardy,
  • Gabriel Ouellet-Lavallée,
  • Catherine Thériault,
  • Chantal Durette and ,
  • Krystel Vincent,
  • Robin Minati,
  • Isabelle Caron,
  • Assya Trofimov,
  • Joel Lanoix and
  • Claude Perreault
  • + 7 authors+ 2 authors

26 September 2026

mRNA vaccines can encode multiple tumor antigens whose presentation ultimately depends on adequate intracellular processing. To evaluate the potential impact of epitope-flanking sequences, we compared the immunogenicity of two mRNA vaccines in the MC...

(This article belongs to the Special Issue Antigen Processing in Autoimmunity and Cancer—Mechanisms and Translational Perspectives)
  • Article
  • Open Access
17 Citations
9,401 Views
23 Pages

Optimizing mRNA-Loaded Lipid Nanoparticles as a Potential Tool for Protein-Replacement Therapy

  • Rocío Gambaro,
  • Ignacio Rivero Berti,
  • María José Limeres,
  • Cristián Huck-Iriart and ,
  • Malin Svensson,
  • Silvia Fraude,
  • Leah Pretsch,
  • Shutian Si,
  • Ingo Lieberwirth and
  • Germán Abel Islan
  • + 7 authors+ 2 authors

Lipid nanoparticles (LNPs) tailored for mRNA delivery were optimized to serve as a platform for treating metabolic diseases. Four distinct lipid mixes (LMs) were formulated by modifying various components: LM1 (ALC-0315/DSPC/Cholesterol/ALC-0159), LM...

(This article belongs to the Special Issue Advances in Nanotechnology-Based Drug Delivery Systems)
  • Article
  • Open Access
17 Citations
6,875 Views
25 Pages

Optimal Chimeric Antigen Receptor (CAR)-mRNA for Transient CAR T Cell Generation

  • Reni Kitte,
  • Robert Serfling,
  • Ulrich Blache,
  • Claudius Seitz and ,
  • Selina Schrader,
  • Ulrike Köhl,
  • Stephan Fricke,
  • Christian Bär and
  • U. Sandy Tretbar
  • + 4 authors+ 0 author

Genetically modified T lymphocytes expressing chimeric antigen receptors (CARs) are becoming increasingly important in the treatment of hematologic malignancies and are also intensively being investigated for other diseases such as autoimmune disorde...

(This article belongs to the Special Issue Chimeric Antigen Receptors Against Cancers and Autoimmune Diseases)
  • Protocol
  • Open Access
7 Citations
7,174 Views
26 Pages

30 November 2022

Transcriptome-wide analysis of RNA-binding partners is commonly achieved using UV crosslinking and immunoprecipitation (CLIP). Individual-nucleotide-resolution CLIP (iCLIP)enables identification of the specific position of the protein–RNA inter...

(This article belongs to the Special Issue Methods and Protocols 2022)
  • Review
  • Open Access
1 Citations
618 Views
38 Pages

18 September 2026

Artificial intelligence is reshaping RNA research by enabling predictive, data-driven workflows across molecular design, therapeutic development, delivery optimization, and analytical quality control. RNA-based medicines, including messenger RNA vacc...

  • Review
  • Open Access
2 Citations
4,501 Views
15 Pages

Therapeutic recombinant proteins are powerful tools used for the treatment of many detrimental diseases such as diabetes, cancer, multiple sclerosis, rheumatoid arthritis, hepatitis, and many more. Their importance in disease therapy is growing over...

(This article belongs to the Section Molecular and Translational Medicine)
  • Review
  • Open Access
1 Citations
1,556 Views
40 Pages

Lipid nanoparticles (LNPs) are now the leading delivery platform for nucleic acid therapeutics, but progress in the field is measured almost entirely by physicochemical and computational proxies rather than by functional properties that determine the...

(This article belongs to the Special Issue Nanoparticles for Local Drug Delivery, 2nd Edition)
  • Review
  • Open Access
51 Citations
9,388 Views
26 Pages

Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles

  • Christophe Delehedde,
  • Luc Even,
  • Patrick Midoux,
  • Chantal Pichon and
  • Federico Perche

Messenger RNA (mRNA) is being extensively used in gene therapy and vaccination due to its safety over DNA, in the following ways: its lack of integration risk, cytoplasmic expression, and transient expression compatible with fine regulations. However...

(This article belongs to the Special Issue Delivery Systems of Plasmid DNA and Messenger RNA for Advanced Therapies)
  • Review
  • Open Access
164 Citations
21,529 Views
16 Pages

Research Advances on the Stability of mRNA Vaccines

  • Feiran Cheng,
  • Yiping Wang,
  • Yu Bai,
  • Zhenglun Liang and ,
  • Qunying Mao,
  • Dong Liu,
  • Xing Wu and
  • Miao Xu
  • + 3 authors+ 0 author

2 March 2023

Compared to other vaccines, the inherent properties of messenger RNA (mRNA) vaccines and their interaction with lipid nanoparticles make them considerably unstable throughout their life cycles, impacting their effectiveness and global accessibility....

(This article belongs to the Special Issue SARS-CoV-2 and mRNA Vaccines)
  • Article
  • Open Access
4 Citations
3,050 Views
16 Pages

Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher Bioconjugation

  • Kexin Geng,
  • Paul J. Rice-Boucher,
  • Elena A. Kashentseva,
  • Igor P. Dmitriev and ,
  • Zhi Hong Lu,
  • S. Peter Goedegebuure,
  • William E. Gillanders and
  • David T. Curiel
  • + 3 authors+ 0 author

20 November 2023

mRNA vaccines have attracted widespread research attention with clear advantages in terms of molecular flexibility, rapid development, and potential for personalization. However, current mRNA vaccine platforms have not been optimized for induction of...

(This article belongs to the Special Issue 15th International Adenovirus Meeting)
  • Review
  • Open Access
33 Citations
11,626 Views
18 Pages

Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules

  • Jingjing Zhang,
  • Yuheng Liu,
  • Chao Li,
  • Qin Xiao and ,
  • Dandan Zhang,
  • Yang Chen,
  • Joseph Rosenecker,
  • Xiaoyan Ding and
  • Shan Guan
  • + 4 authors+ 0 author

The coronavirus disease 2019 (COVID-19) pandemic poses a disruptive impact on public health and the global economy. Fortunately, the development of COVID-19 vaccines based on in vitro-transcribed messenger RNA (IVT mRNA) has been a breakthrough in me...

(This article belongs to the Section Nanomedicine and Nanotechnology)
  • Article
  • Open Access
12 Citations
7,671 Views
15 Pages

Effective Synthesis of High-Integrity mRNA Using In Vitro Transcription

  • Wei He,
  • Xinya Zhang,
  • Yangxiaoyu Zou,
  • Ji Li and ,
  • Chong Wang,
  • Yucai He,
  • Qiuheng Jin and
  • Jianren Ye
  • + 3 authors+ 0 author

mRNA vaccines are entering a period of rapid development. However, their synthesis is still plagued by challenges related to mRNA impurities and fragments (incomplete mRNA). Most impurities of mRNA products transcribed in vitro are mRNA fragments. On...

  • Article
  • Open Access
80 Citations
11,134 Views
15 Pages

Chemical modification of nucleosides in mRNA is an important technology to regulate the immunogenicity of mRNA. In this study, various previously reported mRNA formulations were evaluated by analyzing in vitro protein expression and immunogenicity in...

(This article belongs to the Special Issue New Paradigm of Gene Therapy)
  • Article
  • Open Access
2,623 Views
18 Pages

22 April 2026

Background/Objectives: It is challenging to develop efficient vaccines against intracellular pathogens such as viruses, and since viral infections are one of the main challenges for farmed salmon, a novel vaccine strategy is needed. mRNA vaccines are...

(This article belongs to the Special Issue The Development of mRNA Vaccines)
  • Article
  • Open Access
3 Citations
2,216 Views
17 Pages

Objectives: The COVID-19 pandemic has brought mRNA vaccines to the forefront due to their widespread use. In this study, we explored the potential advantages of the self-amplifying mRNA (saRNA) vaccine over conventional mRNA vaccines. Methods: Initia...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
17 Citations
6,629 Views
12 Pages

Synthetic mRNAs Containing Minimalistic Untranslated Regions Are Highly Functional In Vitro and In Vivo

  • Shahab Mamaghani,
  • Rocco Roberto Penna,
  • Julia Frei,
  • Conrad Wyss and ,
  • Mark Mellett,
  • Thomas Look,
  • Tobias Weiss,
  • Emmanuella Guenova,
  • Thomas M. Kündig and
  • Steve Pascolo
  • + 6 authors+ 1 author

24 July 2024

Synthetic mRNA produced by in vitro transcription (ivt mRNA) is the active pharmaceutical ingredient of approved anti-COVID-19 vaccines and of many drugs under development. Such synthetic mRNA typically contains several hundred bases of non-coding &l...

(This article belongs to the Section Cell and Gene Therapy)
  • Article
  • Open Access
8 Citations
3,767 Views
17 Pages

Iron Oxide Nanoparticle-Mediated mRNA Delivery to Hard-to-Transfect Cancer Cells

  • Jianxi Huang,
  • Guanyou Lin,
  • Taylor Juenke,
  • Seokhwan Chung and ,
  • Nicholas Lai,
  • Tianxin Zhang,
  • Tianyi Zhang and
  • Miqin Zhang
  • + 3 authors+ 0 author

mRNA-based therapeutics have emerged as a promising strategy for cancer treatment. However, the effective delivery of mRNA into hard-to-transfect cancer cells remains a significant challenge. This study introduces a novel approach that utilizes iron...

(This article belongs to the Special Issue Nanoparticles for Imaging and Drug Delivery)
  • Review
  • Open Access
166 Citations
25,349 Views
44 Pages

Recent Advances in Lipid Nanoparticles for Delivery of mRNA

  • Lei Yang,
  • Liming Gong,
  • Ping Wang,
  • Xinghui Zhao and ,
  • Feng Zhao,
  • Zhijie Zhang,
  • Yunfei Li and
  • Wei Huang
  • + 3 authors+ 0 author

Messenger RNA (mRNA), which is composed of ribonucleotides that carry genetic information and direct protein synthesis, is transcribed from a strand of DNA as a template. On this basis, mRNA technology can take advantage of the body’s own trans...

(This article belongs to the Special Issue Development of Nucleic Acid Delivery System)
  • Article
  • Open Access
1,904 Views
11 Pages

Human β-Defensin 23 as a Carrier for In Vitro and In Vivo Delivery of mRNA

  • Kyoung-Ran Kim,
  • Junghyun Kim,
  • Seunghye Cho and
  • Dae-Ro Ahn

The successful application of mRNA therapeutics hinges on the effective intracellular delivery of mRNA both in vitro and in vivo. However, this remains a formidable challenge due to the polyanionic nature, longitudinal shape, and low nuclease resista...

(This article belongs to the Special Issue The 15th Anniversary of Pharmaceutics—Advances and Future Trends in Drug Delivery)
  • Review
  • Open Access
7 Citations
5,689 Views
29 Pages

This review provides an overview covering mRNA from its use in the COVID-19 pandemic to cancer immunotherapy, starting from the selection of appropriate antigens, tumor-associated and tumor-specific antigens, neoantigens, the basics of optimizing the...

(This article belongs to the Section Molecular and Translational Medicine)
  • Review
  • Open Access
20 Citations
5,022 Views
18 Pages

mRNA Technology and Mucosal Immunization

  • Antonio Toniolo,
  • Giuseppe Maccari and
  • Giovanni Camussi

17 June 2024

Current mRNA vaccines are mainly administered via intramuscular injection, which induces good systemic immunity but limited mucosal immunity. Achieving mucosal immunity through mRNA vaccination could diminish pathogen replication at the entry site an...

  • Review
  • Open Access
328 Citations
65,391 Views
35 Pages

9 September 2020

Messenger ribonucleic acid (mRNA)-based drugs, notably mRNA vaccines, have been widely proven as a promising treatment strategy in immune therapeutics. The extraordinary advantages associated with mRNA vaccines, including their high efficacy, a relat...

(This article belongs to the Section Molecular Biophysics)
  • Review
  • Open Access
17 Citations
9,996 Views
27 Pages

1 March 2025

Modernization of existing methods for the delivery of mRNA is vital in advanced therapeutics. Traditionally, mRNA has faced obstacles of poor stability due to enzymatic degradation. This work examines cutting-edge formulation and emerging techniques...

(This article belongs to the Special Issue Novel Materials for Biomedical Applications: 2nd Edition)
  • Review
  • Open Access
1 Citations
1,159 Views
22 Pages

Respiratory mucosal vaccination can induce robust humoral and cellular immune responses, as well as effective mucosal immunity at the primary site of pathogen entry, and has been shown to provide superior protection against respiratory viral infectio...

(This article belongs to the Special Issue Mucosal Immunity and Vaccine)
  • Review
  • Open Access
932 Views
21 Pages

This review summarizes mechanisms regulating mRNA translation under cellular stress and highlights design strategies to improve translation efficiency and stability in the gene therapy of human diseases. mRNA-based therapeutics are emerging as a vers...

(This article belongs to the Topic Advances in Gene Therapy of Human Diseases)
  • Article
  • Open Access
10 Citations
5,187 Views
16 Pages

Rapid Identity and Quantity CQA Test for Multivalent mRNA Drug Product Formulations

  • Rachel Y. Gao,
  • Christine M. Riley,
  • Evan Toth,
  • Rebecca H. Blair and ,
  • Megan N. Gerold,
  • Caitlin McCormick,
  • Amber W. Taylor,
  • Tianjing Hu,
  • Kathy L. Rowlen and
  • Erica D. Dawson
  • + 5 authors+ 0 author

12 October 2022

The COVID-19 pandemic highlighted mRNA as a promising platform for vaccines and therapeutics. Many of the analytical tools used to characterize the critical quality attributes of mRNA are inherently singleplex and are not necessarily optimal from a l...

(This article belongs to the Special Issue Feature Papers of DNA and mRNA Vaccines)
  • Article
  • Open Access
1 Citations
848 Views
19 Pages

29 April 2026

Background: An accurate, sensitive, and robust potency assay is essential for the quality control of mRNA drug substances, which are characterized by complex manufacturing processes, intricate molecular structures, and high susceptibility to degradat...

(This article belongs to the Special Issue The Development of mRNA Vaccines)
  • Review
  • Open Access
206 Citations
23,570 Views
42 Pages

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives

  • Itziar Gómez-Aguado,
  • Julen Rodríguez-Castejón,
  • Mónica Vicente-Pascual,
  • Alicia Rodríguez-Gascón and ,
  • María Ángeles Solinís and
  • Ana del Pozo-Rodríguez
  • + 1 author+ 0 author

20 February 2020

The use of messenger RNA (mRNA) in gene therapy is increasing in recent years, due to its unique features compared to plasmid DNA: Transient expression, no need to enter into the nucleus and no risk of insertional mutagenesis. Nevertheless, the clini...

  • Article
  • Open Access
30 Citations
7,975 Views
19 Pages

Untranslated Region Sequences and the Efficacy of mRNA Vaccines against Tuberculosis

  • Vasiliy Reshetnikov,
  • Ilya Terenin,
  • Galina Shepelkova,
  • Vladimir Yeremeev and ,
  • Semyon Kolmykov,
  • Maxim Nagornykh,
  • Elena Kolosova,
  • Tatiana Sokolova,
  • Olga Zaborova and
  • Roman Ivanov
  • + 13 authors+ 8 authors

mRNA vaccines have been shown to be effective in combating the COVID-19 pandemic. The amount of research on the use of mRNAs as preventive and therapeutic modalities has undergone explosive growth in the last few years. Nonetheless, the issue of the...

(This article belongs to the Section Molecular Immunology)
  • Review
  • Open Access
9 Citations
6,173 Views
18 Pages

Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy

  • Theodora Katopodi,
  • Savvas Petanidis,
  • Eirini Grigoriadou,
  • Doxakis Anestakis and ,
  • Charalampos Charalampidis,
  • Ioanna Chatziprodromidou,
  • George Floros,
  • Panagiotis Eskitzis,
  • Paul Zarogoulidis and
  • Christoforos Kosmidis
  • + 18 authors+ 13 authors

Extensive research into mRNA vaccines for cancer therapy in preclinical and clinical trials has prepared the ground for the quick development of immune-specific mRNA vaccines during the COVID-19 pandemic. Therapeutic cancer vaccines based on mRNA are...

(This article belongs to the Special Issue Innovative Drug Release and Vaccine Delivery Systems)
  • Review
  • Open Access
9 Citations
6,944 Views
14 Pages

mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses

  • Janan Shoja Doost,
  • Fatemeh Fazel,
  • Nitish Boodhoo and
  • Shayan Sharif

1 September 2024

Vaccination has led to significant dismantling of infectious diseases worldwide. Since the dawn of the SARS-CoV-2 pandemic, there has been increased popularity in the usage and study of the mRNA vaccine platform. Here, we highlight fundamental knowle...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Feature Paper
  • Article
  • Open Access
9 Citations
2,116 Views
22 Pages

15 December 2024

Background: Gastric cancer is one of the most prevalent gastrointestinal cancers. Mortality is high, and improved treatments are needed. A better understanding of the pathophysiology of the disease and discovery of biomarkers for targeted therapies a...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)

of 24